Tirzepatide — Peptide Glossary | RetatrutideCompare

A dual GLP-1/GIP receptor agonist developed by Eli Lilly. FDA-approved as Mounjaro (diabetes) and Zepbound (obesity). A precursor concept to Retatrutide's triple agonist design.
Category: Research Peptides & Compounds